Pharmaceutical manufacturers running SCADA systems, historian servers, and IoT-connected production equipment on unsegmented OT networks face an average regulatory remediation cost of $4.2M per cybersecurity incident — before the FDA 21 CFR Part 11 data integrity investigation that follows. In 2024, 68 percent of pharmaceutical OT environments audited by industry security firms contained at least one unpatched critical vulnerability on equipment directly controlling GMP-validated processes. The vulnerability existed. The asset was registered. The patch was available. The failure was governance — no documented change control for OT patches, no network segmentation proof for auditors, no IoT device inventory tied to validated equipment records. That gap is exactly what Oxmaint closes. Book a demo to see how Oxmaint structures pharmaceutical OT cybersecurity governance, device inventory, and audit-ready compliance documentation across your manufacturing network.
Pharmaceutical OT cybersecurity requires documented control across four domains: connected equipment asset inventory with validated system boundaries, OT network segmentation evidence for FDA and EMA audit, SCADA and historian patch management under GMP change control, and IoT device lifecycle governance tied to equipment qualification records. Oxmaint unifies all four into a single auditable system — connecting IT security operations to the validated equipment records that regulators inspect.
Four OT Security Domains Carrying the Highest Regulatory Risk in Pharma
Each domain has distinct FDA, EMA, and IEC 62443 obligations — and a specific failure mode when managed outside a validated, auditable system. Book a demo to see how Oxmaint structures all four into a unified compliance framework.
Every SCADA workstation, PLC, historian server, IoT sensor, and network switch within a GMP-validated system boundary must be inventoried with firmware version, qualification status, and network zone assignment. Undocumented assets inside a validated boundary trigger data integrity findings. Oxmaint maintains the OT asset registry with validation status, change history, and network zone — directly linked to equipment qualification records for FDA inspection readiness.
FDA's 2023 cybersecurity guidance for drug manufacturers requires documented network architecture showing segmentation between corporate IT and OT process control networks, with access control records for every remote session into validated systems. Oxmaint generates the segmentation evidence record and logs every authorized OT access event — providing the documented proof auditors require without manual screenshot collection before each inspection.
Security patches applied to validated OT systems — SCADA servers, DCS workstations, historian platforms — require documented change control, impact assessment on validated functionality, and requalification evidence where required. Ad-hoc patching without change control is an Annex 11 violation. Oxmaint routes OT patch work orders through GMP change control workflow, captures validation impact assessments, and archives requalification evidence against the affected system record.
Connected sensors, smart meters, wireless PAT instruments, and RTLS devices operating within GMP manufacturing areas require documented qualification, cybersecurity risk assessment, and end-of-life decommissioning records. Unmanaged IoT proliferation inside validated areas creates undocumented system boundary expansion. Oxmaint tracks every IoT device from procurement qualification through decommissioning — with cybersecurity risk assessment linked to the device record and automated alerts when firmware support lifecycle ends.
OT Asset Inventory. Patch Change Control. Network Segmentation Evidence. All Audit-Ready.
Oxmaint connects pharmaceutical OT security operations to the validated equipment records FDA and EMA inspectors audit — closing the gap between IT security tools and GMP compliance documentation. Book a demo to see the OT cybersecurity compliance workflow for your manufacturing network.
Regulatory Framework Coverage — Pharmaceutical OT Cybersecurity
Pharmaceutical manufacturers operating across jurisdictions face layered cybersecurity obligations — from FDA guidance to EU Annex 11 to IEC 62443 supply chain qualification requirements. Oxmaint pre-configures compliance templates for each framework.
| Region | Regulatory Framework | Key OT Cybersecurity Obligation | Oxmaint Coverage |
|---|---|---|---|
| USA | FDA 21 CFR Part 11, FDA Cybersecurity Guidance 2023, NIST CSF, NIST SP 800-82 (OT Security) | OT asset inventory with validation status, network segmentation documentation, cybersecurity incident reporting, patch management under change control | FDA-aligned OT asset registry, validated system boundary documentation, change control workflow for OT patches, incident log with regulatory notification tracking |
| EU / EEA | EU Annex 11 (Computerised Systems), EMA Reflection Paper on Cybersecurity, NIS2 Directive, IEC 62443 | Validated system change control for all OT modifications, access control and audit trail for computerised systems, cybersecurity risk assessment for critical infrastructure | Annex 11-compliant change control for OT, audit trail per validated system, NIS2 incident notification workflow, IEC 62443 zone and conduit documentation |
| UK | MHRA GxP Data Integrity Guidance, UK Cyber Essentials Plus, UK NIS Regulations, GAMP 5 | OT system inventory and access control aligned with MHRA data integrity expectations, Cyber Essentials Plus controls evidence for NHS and regulated supply chains | MHRA-aligned OT asset and access records, Cyber Essentials Plus control documentation, GAMP 5 category-based qualification records in Oxmaint |
| Global / MNC | IEC 62443 (all parts), ICH Q10 Pharmaceutical Quality System, ISPE GAMP 5, ISO 27001 + 27019 | IEC 62443 security level assessment per OT zone, ICH Q10 change management for validated systems, ISO 27001 ISMS scope covering OT environments | IEC 62443 security level documentation, ICH Q10 change management integration, ISO 27001 evidence package export, multi-site OT asset inventory in single Oxmaint instance |
Cybersecurity Compliance KPIs — Pharmaceutical OT Benchmark
Operational Results — Pharmaceutical Sites Using Oxmaint OT Security Governance
From Spreadsheet Exposure to FDA Inspection-Ready OT Governance — in 8 Weeks
Pharmaceutical sites that deploy Oxmaint close the gap between IT security operations and GMP compliance documentation before the next FDA or EMA inspection — not in response to it. Book a demo to see your current OT cybersecurity compliance posture assessed in the first deployment session.
Oxmaint OT Cybersecurity Platform — Core Capabilities for Pharma
Every OT asset — SCADA, PLC, historian, IoT sensor — registered with validation status, firmware version, network zone, and qualification record. Boundary changes trigger automatic change control workflow.
Security patches routed through validated change control — impact assessment, requalification evidence, and rollback documentation captured per work order and archived against the validated system record.
IEC 62443 zone and conduit documentation generated and maintained in Oxmaint — providing the network architecture evidence FDA and EMA inspectors require without manual diagram reconstruction before each audit.
Every remote session, privileged access event, and configuration change on a validated OT system logged with user identity, timestamp, and business justification — meeting 21 CFR Part 11 and Annex 11 audit trail requirements automatically.
Connected devices qualified, risk-assessed, and decommissioned within a governed lifecycle — firmware end-of-life alerts automated, qualification documentation linked to device record for regulatory inspection.
Complete OT cybersecurity evidence package — asset inventory, change records, access logs, incident reports — exportable in 4 hours for FDA inspection response, EMA audit, or IEC 62443 certification review.
Frequently Asked Questions
Close the OT Cybersecurity Compliance Gap Before the Next FDA Inspection
Validated OT asset inventory, GMP patch change control, network segmentation documentation, and IEC 62443 zone governance — all live in Oxmaint within 8 weeks, no IT project required. Book a demo with your VP of Manufacturing or Head of Quality and see the full OT cybersecurity compliance workflow configured for your validated production environment.
